The UK stock market is brimming with hidden value. Here are some top picks to consider in July

I’m looking for the most promising shares on the UK stock market this month. Here are three that I think have good growth potential.

| More on:
Number three written on white chat bubble on blue background

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The UK stock market is doing well this year but things have slowed down as the summer holidays approach. However, the following three companies don’t appear to be slowing down at all.


Wise (LSE: WISE) catapulted to fame about a decade ago after starting life as Transferwise, a service offering low-cost international money transfers. Foreign workers in the UK jumped at the opportunity to send money home at a fraction of typical high street bank fees. The company has since restructured itself into a fully-fledged online bank, offering savings accounts, debit cards, and business banking.

It released its 2024 full-year earnings earlier this month with revenue up 46% from last year and earnings per share (EPS) beating analyst expectations by 14%. Yet despite the positive results, the share price crashed 17% following the report.

This was because management said it expects growth to slow in the coming year, down to 15%-20%. That’s quite a drop from the 31% growth it experienced this past year. However, that doesn’t mean the share price will necessarily suffer. Between July 2022 and July 2023, the share price increased by over 100%.

Could it repeat that performance again? It’s hard to say but the current price point makes it a stock worth considering.

Games Workshop

The Games Workshop (LSE: GAW) provides a unique service with very little competition and a loyal fanbase. It sells board games and miniature figurines for popular fantasy games like Warhammer 40,000.

The share price shot up 13% this week after the company posted a positive trading update. It expects a 20% rise in licensing income this year and 17% increase in pre-tax profits, plus 10% revenue growth. Those figures aren’t guaranteed, of course, but they seem to have caught the attention of investors.

In today’s increasingly online world, it’s surprising to me that such products are still so popular. But consumer habits could easily change and an economic downturn would threaten the company’s profits. Since it sells expensive premium products, customers are unlikely to prioritise them if money is tight.

Another concern is the share price. It’s now quite high so further growth this year could be limited. But with a highly devoted fanbase and strong potential in it’s intellectual property, its future prospects could be promising.

Hikma Pharmaceuticals

The Hikma Pharmaceuticals (LSE: HIK) share price fell sharply in late 2021 but has risen 67% since late 2022. The growth has not gone unnoticed. This week, both Deutsche Bank and Citi put in a ‘buy’ rating for the stock.

However, the firm is at risk from stiff competition in the pharmaceutical industry. And the drug maker mainly focuses on the generic drug market in the Middle East and North Africa (MENA). This area is at risk from geopolitical upheaval, which could affect the company’s profits.

It also has a higher-than-average price-to-earnings (P/E) ratio of 29.3, so the current price may be a bit high. The company seems to be doing well, though. It recently bought $135m worth of rival firm Xellia’s assets, including a facility in Ohio. The acquisition highlights the company’s strong expansion goals and will help advance its operations in the US.

Sure, it’s no Pfizer or AstraZeneca but its worth considering as a more diversified option in the pharmaceuticals industry.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Mark Hartley has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc, Games Workshop Group Plc, Hikma Pharmaceuticals Plc, and Wise Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

After crashing 50%, is now the perfect time to buy this world-class FTSE 250 share?

The worst-performing share on the FTSE 250 over the last year is also the most exciting one of all. How…

Read more »

Illustration of flames over a black background
Investing Articles

Just released: July’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

Investing Articles

Is this one of the FTSE 100’s best-value growth shares?

Looking for great-value recovery shares to buy today? Based on City forecasts, this could be one of the best that…

Read more »

Investing Articles

Will the Tesco share price hit a 10-year high in 2024?

Up from 200p less than two years ago, the Tesco share price has enjoyed impressive growth lately. Now I'm considering…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Nearing its 12-year low, this FTSE growth stock could be the bargain of the year!

Harvey Jones has happy memories of owning this FTSE 100 growth stock. Now he's wondering whether to take a trip…

Read more »

Investing Articles

BT share price: a bargain or one to avoid?

This Fool has been keeping tabs on the BT share price. Despite looking cheap, he's steering clear of the stock…

Read more »

Electric cars charging in station
Investing Articles

Where will Tesla stock be in 5 years? Here’s what the experts say

The analysts' outlook for Tesla stock in the next few years seems to be all over the place, as the…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

3 reasons why I predict UK shares will soar over the next 12 months!

Our writer believes there are plenty of reasons why UK shares will do well over the next year or so.…

Read more »